tradingkey.logo
tradingkey.logo
Suchen

Petmed Express Inc

PETS
Zur Watchlist hinzufügen
1.980USD
-0.010-0.50%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
42.34MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Petmed Express Inc Unternehmen

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Petmed Express Inc Informationen

BörsenkürzelPETS
Name des UnternehmensPetmed Express Inc
IPO-datumApr 06, 2000
CEOCampbell (Leslie C.G)
Anzahl der mitarbeiter173
WertpapierartOrdinary Share
GeschäftsjahresendeApr 06
Addresse420 South Congress Avenue
StadtDELRAY BEACH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33445
Telefon15614264444
Websitehttps://www.1800petmeds.com/
BörsenkürzelPETS
IPO-datumApr 06, 2000
CEOCampbell (Leslie C.G)

Führungskräfte von Petmed Express Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gian M. Fulgoni
Dr. Gian M. Fulgoni
Independent Director
Independent Director
132.30K
-19.70%
Ms. Leslie C.G. Campbell
Ms. Leslie C.G. Campbell
Executive Chairman of the Board, President, Interim Chief Executive Officer
Executive Chairman of the Board, President, Interim Chief Executive Officer
82.50K
-3.03%
Mr. Peter Batushansky
Mr. Peter Batushansky
Independent Director
Independent Director
36.37K
--
Mr. James LaCamp
Mr. James LaCamp
Independent Director
Independent Director
34.87K
--
Mr. Justin L. Mennen
Mr. Justin L. Mennen
Lead Independent Director
Lead Independent Director
--
--
Ms. Leah A. Solivan
Ms. Leah A. Solivan
Independent Director
Independent Director
--
--
Mr. Doug Krulik
Mr. Doug Krulik
Chief Accounting Officer, Interim Principal Financial Officer, and Treasurer
Chief Accounting Officer, Interim Principal Financial Officer, and Treasurer
--
--
Mr. Reed Anderson
Mr. Reed Anderson
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gian M. Fulgoni
Dr. Gian M. Fulgoni
Independent Director
Independent Director
132.30K
-19.70%
Ms. Leslie C.G. Campbell
Ms. Leslie C.G. Campbell
Executive Chairman of the Board, President, Interim Chief Executive Officer
Executive Chairman of the Board, President, Interim Chief Executive Officer
82.50K
-3.03%
Mr. Peter Batushansky
Mr. Peter Batushansky
Independent Director
Independent Director
36.37K
--
Mr. James LaCamp
Mr. James LaCamp
Independent Director
Independent Director
34.87K
--
Mr. Justin L. Mennen
Mr. Justin L. Mennen
Lead Independent Director
Lead Independent Director
--
--
Ms. Leah A. Solivan
Ms. Leah A. Solivan
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Petmed Express Inc?

Die fünf größten Anteilseigner von Petmed Express Inc sind: Dr. Gian M. Fulgoni

Wie viele Institutionen halten Anteile an Petmed Express Inc (PETS)?

Mit Stand vom 2026Q1 halten 256 Institutionen Anteile an Petmed Express Inc, mit einem Gesamtmarktwert von etwa 8.79M, was 41.08% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1558091.00 gestiegen.

Was ist die größte Einnahmequelle von Petmed Express Inc?

Am 2026Q1 erzielte das Geschäft mit Reorder sales für Petmed Express Inc den höchsten Umsatz in Höhe von 34.02M, was 83.67% des Gesamtumsatzes entspricht.